<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id>
<journal-title>Frontiers in Human Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Hum. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5161</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnhum.2021.680295</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Fast Ripples as a Biomarker of Epileptogenic Tuber in Tuberous Sclerosis Complex Patients Using Stereo-Electroencephalograph</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Yangshuo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1269730/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yuan</surname> <given-names>Liu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Shaohui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liang</surname> <given-names>Shuangshuang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname> <given-names>Xiaoman</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Tinghong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Xiaofeng</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/408990/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Liang</surname> <given-names>Shuli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/63009/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Functional Neurosurgery, Beijing Children&#x2019;s Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurosurgery, Fourth Medical Center, General Hospital of PLA</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Bioland Laboratory</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Changming Wang, Xuanwu Hospital, Capital Medical University, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Zhixian Yang, Peking University First Hospital, China; James Tao, University of Chicago, United States</p></fn>
<corresp id="c001">&#x002A;Correspondence: Shuli Liang, <email>liangsl_304@sina.com</email></corresp>
<corresp id="c002">Xiaofeng Yang, <email>xiaofengyang@yahoo.com</email></corresp>
<fn fn-type="other" id="fn002"><p><sup>&#x2020;</sup>These authors share first authorship</p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Brain Imaging and Stimulation, a section of the journal Frontiers in Human Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>15</volume>
<elocation-id>680295</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Wang, Yuan, Zhang, Liang, Yu, Liu, Yang and Liang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Wang, Yuan, Zhang, Liang, Yu, Liu, Yang and Liang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p><bold>Objectives:</bold> To evaluate the value of fast ripples (FRs) (200&#x2013;500 Hz) recorded with stereo-electroencephalograph (SEEG) in the localization of epileptogenic tubers in patients with tuberous sclerosis complex (TSC).</p>
<p><bold>Methods:</bold> Seventeen TSC patients who underwent preoperative SEEG examination and resective epilepsy surgery were retrospectively enrolled. They were divided into two groups according to the seizure control at 1-year postoperative follow-up. The occurrence frequencies of FRs were automatically counted, and the FR rate was calculated. The high FR rate was defined as FR rate &#x2267;0.5. According to different positions, the contacts&#x2019; locations were divided into three groups: inner of the tubers, the junction region of the tubers, and out of the tubers. The influence factors of postoperative seizure freedom were also analyzed.</p>
<p><bold>Results:</bold> Twelve patients reached postoperative seizure freedom at 1-year follow-up. In total, FRs were found in 24.2% of the contacts and 67.1% of the tubers in all assessed patients. There were 47 high FR rate contacts localized in the junction region of the tubers, which was 62.7% of the 75 high FR rate contacts in total and was 8.4% of the total 561 contacts localized in the junction region of the tubers. Total removal of epileptogenic tubers and total resection of the high FR rate tubers/contacts were associated with postoperative seizure freedom (<italic>P</italic> &#x003C; 0.05).</p>
<p><bold>Conclusion:</bold> FRs could be extensively detected in TSC patients using SEEG, and high FR rate contacts were mostly localized in the junction region of the epileptogenic tuber, which could aid in the localization of epileptogenic tubers.</p>
</abstract>
<kwd-group>
<kwd>epilepsy surgery</kwd>
<kwd>epileptogenic zone</kwd>
<kwd>fast ripples</kwd>
<kwd>stereo-electroencephalography(SEEG)</kwd>
<kwd>tuberous sclerosis complex</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="36"/>
<page-count count="9"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Highlights</title>
<list list-type="simple">
<list-item>
<label>-</label>
<p>Fast ripples can be detected extensively by stereo-electroencephalograph in tuberous sclerosis complex patients.</p>
</list-item>
<list-item>
<label>-</label>
<p>Fast ripples with high rates of occurrence frequency can be used to localize epileptogenic tubers.</p>
</list-item>
<list-item>
<label>-</label>
<p>Fast ripples with high rates of occurrence frequency are mostly detected in the junction region of the epileptogenic tubers.</p>
</list-item>
</list>
</sec>
<sec id="S2">
<title>Introduction</title>
<p>Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome: 85% of them with <italic>TSC1</italic> or <italic>TSC2</italic> gene mutation (<xref ref-type="bibr" rid="B2">Curatolo and Maria, 2013</xref>; <xref ref-type="bibr" rid="B1">Kingswood et al., 2014</xref>; <xref ref-type="bibr" rid="B3">Cui et al., 2018</xref>). Epilepsy is the most common neurological comorbidity, occurring in 90% of TSC patients (<xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>; <xref ref-type="bibr" rid="B3">Cui et al., 2018</xref>; <xref ref-type="bibr" rid="B4">Liu et al., 2020</xref>). With medication-resistant epilepsy, there are additional standard-of-care approaches for seizure control in TSC patients beyond conventional antiseizure medications, and improved intellectual development has been found to be related to longer periods of seizure remission (<xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>). Everolimus (a rapamycin analog), ketogenic diet therapy, and vagus nerve stimulation have been reported to have a greater than 50% reduction in seizure burden in more than 70% of patients with TSC (<xref ref-type="bibr" rid="B7">Krueger et al., 2013</xref>; <xref ref-type="bibr" rid="B6">Overwater et al., 2015</xref>; <xref ref-type="bibr" rid="B8">Park et al., 2017</xref>). Despite those treatments, more than 50% of patients with TSC still present intractable epilepsy. Several studies have demonstrated that resective surgery is the most effective treatment for TSC patients with medication-resistant epilepsy. Furthermore, systematic reviews have shown that 56&#x2013;59% of TSC patients who underwent resective surgery achieved seizure freedom, and 68&#x2013;75% experienced a worthwhile reduction (&#x003E;90%) in seizure frequency (<xref ref-type="bibr" rid="B9">Jansen et al., 2007</xref>; <xref ref-type="bibr" rid="B10">Fallah et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>; <xref ref-type="bibr" rid="B4">Liu et al., 2020</xref>).</p>
<p>Nevertheless, the greatest barrier to surgical intervention in TSC is the difficulty associated with localizing epileptogenic tuber(s), as multiple and bilateral cortical tubers often occur in cases with TSC (<xref ref-type="bibr" rid="B10">Fallah et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>; <xref ref-type="bibr" rid="B11">Yu et al., 2019</xref>). High-resolution magnetic resonance imaging (MRI), magnetoencephalography, <sup>11</sup>C-positron emission tomography (PET), MRI-PET coregistration, subtraction ictal single photon emission computed tomography coregistered to MRI, and intracranial electroencephalography (EEG) have been utilized historically during preoperative assessments (<xref ref-type="bibr" rid="B15">Chugani et al., 2013</xref>; <xref ref-type="bibr" rid="B14">Kargiotis et al., 2014</xref>; <xref ref-type="bibr" rid="B13">Yogi et al., 2015</xref>; <xref ref-type="bibr" rid="B12">Sun et al., 2018</xref>; <xref ref-type="bibr" rid="B11">Yu et al., 2019</xref>). However, according to literatures with 10-year postoperative follow-ups, approximately 50% of TSC patients still suffered seizures following epilepsy surgery (<xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>; <xref ref-type="bibr" rid="B12">Sun et al., 2018</xref>; <xref ref-type="bibr" rid="B4">Liu et al., 2020</xref>). To reach better postoperative seizure control, it is essential to develop newer and more efficient approaches to localize the epileptogenic tubers more accurately in TSC patients (<xref ref-type="bibr" rid="B11">Yu et al., 2019</xref>).</p>
<p>High-frequency oscillations (HFOs) (80&#x2013;500 Hz) have been demonstrated to be a promising biomarker of epileptogenicity by many studies (<xref ref-type="bibr" rid="B16">Jacobs et al., 2008</xref>; <xref ref-type="bibr" rid="B17">Cr&#x00E9;pon et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Fedele et al., 2017</xref>). The link between HFOs and the epileptogenic zone has previously been demonstrated according to clinical data indicating a correlation between the increased removal of areas with ictal HFOs and improved postsurgical outcomes (<xref ref-type="bibr" rid="B17">Cr&#x00E9;pon et al., 2010</xref>; <xref ref-type="bibr" rid="B20">Fedele et al., 2019</xref>). However, HFOs extending beyond the epileptogenic zone were reported in the majority of patients (<xref ref-type="bibr" rid="B19">Jacobs et al., 2010</xref>). <xref ref-type="bibr" rid="B21">Haegelen et al. (2013)</xref> reported that the removal of HFO-generating areas might lead to improved surgical outcomes in patients with temporal lobe epilepsy, but not in those with extratemporal lobe epilepsy. How to distinguish pathological ripples from physiological ripples is an obstacle in the clinical application of HFOs in the localization of epileptogenic zones. It is also reported that fast ripples (FRs) (200&#x2013;500 Hz), but not ripples (80&#x2013;200 Hz), correlate with seizure control in patients with medication-resistant epilepsy (<xref ref-type="bibr" rid="B17">Cr&#x00E9;pon et al., 2010</xref>; <xref ref-type="bibr" rid="B22">Akiyama et al., 2011</xref>; <xref ref-type="bibr" rid="B23">Ren et al., 2018</xref>).</p>
<p>In previous literatures, HFOs have been used for preoperative assessment in TSC patients with intracranial EEG recorded with subdural electrodes (<xref ref-type="bibr" rid="B24">Okanishi et al., 2014</xref>; <xref ref-type="bibr" rid="B25">Fujiwara et al., 2016</xref>). However, FRs recorded with stereo-EEG (SEEG) in TSC patients have not been studied before. Therefore, this study aims to utilize SEEG to investigate the value of FRs in localizing epileptogenic tuber(s) in TSC patients with epilepsy. We hypothesize that FRs may be a biomarker in the localization of epileptogenic tubers, and the distribution of FRs may be different in different parts of cortical tubers.</p>
</sec>
<sec id="S3" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S3.SS1">
<title>Patient Selection and Inclusion Criteria</title>
<p>Patients were enrolled following the inclusion criteria: subjects who underwent preoperative evaluations with SEEG, subjects who finished resective surgeries from January 2016 to December 2018 in our epilepsy centers in Beijing, patients who had met the criteria of medication-resistant epilepsy for no less than 2 years, and subjects who had previously been diagnosed with TSC in accordance with the revised diagnostic criteria of Northrup (<xref ref-type="bibr" rid="B26">Northrup and Krueger, 2013</xref>). The exclusion criteria included subjects with one to three cortical tubers; subjects with obvious lymphangioleiomyomatosis, renal angiomyolipomas, and cardiac rhabdomyomas; and patients with serious cardiac, renal, or lung dysfunction (<xref ref-type="bibr" rid="B27">Liang et al., 2010</xref>, <xref ref-type="bibr" rid="B5">2017</xref>). This study was approved by the Ethics Committee of the Fourth Medical Center, General Hospital of PLA, and the written consent was not signed for a retrospective study.</p>
</sec>
<sec id="S3.SS2">
<title>Non-invasive Preoperative Evaluation</title>
<p>Non-invasive preoperative evaluations included neurological history (e.g., clinical seizure semiology) and physical examination, MRI, long-term scalp video EEG recordings, PET, and neuropsychological testing. MRI scans included 3.0-T routine axial T1-weighted, T2-weighted, and diffusion-weighted imaging; sagittal T1-weighted imaging; and 1-mm thickness by zero interval axial and coronal T2&#x2013;fluid-attenuated inversion recovery (FLAIR) imaging. The number of cortical tubers was counted using axial T2-FLAIR images. Neuropsychological tests included Wechsler Intelligence Scale IV (Chinese revision) for measuring intelligence quotient and the overall subscale of quality of life on the Quality of Life in Childhood Epilepsy Questionnaire.</p>
</sec>
<sec id="S3.SS3">
<title>SEEG Examination and Epileptogenic Tuber Localization</title>
<p>Stereo-electroencephalograph electrodes with 8&#x2013;16 contacts, 0.8 mm in diameter, 2 mm in length for contacts, and 1.5 mm in intercontact interval (Huake Company, Beijing, China) were embedded under generalized anesthesia for recording intracranial EEGs, in order to localize the epileptogenic tubers in TSC patients with multiple potential epileptogenic cortical tubers. The SEEG electrodes covered the potential epileptogenic cortical tubers, which had calcifications or cystic changes on MRI, had abnormal findings on PET images, or were localized in regions with focal ictal symptoms or focal ictal and/or interictal epileptiform discharges on scalp EEGs (<xref ref-type="bibr" rid="B5">Liang et al., 2017</xref>). In addition, the adjacent cortexes to those tubers were also covered with SEEG electrodes (<xref ref-type="bibr" rid="B11">Yu et al., 2019</xref>).</p>
<p>Data from a minimum of five habitual seizures episodes were required for further analysis and identification. The epileptogenic tuber was identified as the first tuber with initial rhythmical discharge on SEEG before clinical seizure attack. Propagating tubers were identified by secondary rhythmical discharges on SEEG before or after clinical seizure attack in 10 s after ictal EEG onset. If more than one tuber exhibited an initial rhythmical discharge on SEEG during the same seizure or during different seizure episodes, comprehensive analysis was performed by combining MRI-PET image fusion data and clinical semiology to distinguish independent epileptogenic tubers from propagating tubers (<xref ref-type="bibr" rid="B11">Yu et al., 2019</xref>; <xref ref-type="bibr" rid="B4">Liu et al., 2020</xref>).</p>
</sec>
<sec id="S3.SS4">
<title>FR Recording and Analysis</title>
<p>Interictal SEEG signals were recorded with an EEG acquisition system (Natus, United States) with a sampling frequency of 0&#x2013;4,000 Hz (<xref ref-type="bibr" rid="B23">Ren et al., 2018</xref>). Five segments of 5-min interictal SEEGs during slow-wave sleep at midnight were used to analyze the occurrence frequency of FRs. Those segments were separated from each other and from seizure episodes by a minimum of 2 h. Slow-wave sleep was defined by the presence of more than 25% delta activity in 30-s epochs by visual inspection (<xref ref-type="bibr" rid="B28">Urrestarazu et al., 2007</xref>).</p>
<p>Bipolar montage with pairs of two adjacent EEG electrodes successively connected was used. The reference electrodes were excluded from the dataset. The automated detection of FRs was performed using software and previously described methods (<xref ref-type="bibr" rid="B23">Ren et al., 2018</xref>). During analysis, each contact and tuber with FRs were counted for every epoch and then averaged for a 5-min interval. The occurrence frequency of FRs was described with the number of FRs and the rate of FRs in each contact. The FR rate was calculated using the following formula: (the number of FRs in this contact/the maximum number of FRs among all contacts of this patient). A contact was defined as an FR contact when the occurrence frequency of FRs was more than 0.2/min in this contact. Similarly, a tuber with no less than one FR contact was defined as an FR tuber. In addition, when the FR rate was more than 0.5 in a certain contact (<xref ref-type="bibr" rid="B29">Burnos et al., 2014</xref>), we defined it as a high FR rate contact. Also, if no less than one high FR rate contact occurred in a tuber, we defined the tuber as a high FR rate tuber.</p>
<p>According to the positional relation of contacts and tubers, the locations of contacts were defined as inner of the tuber, junction region of the tuber, and out of the tuber. The inner of the tuber was defined as inner three-fourths of the tuber. The junction region of the tuber was defined as the outer quarter area of the tuber border on MRI-T2-FLAIR plus the adjacent cortical area of gyrus with tuber involvement. <italic>Out of the tuber</italic> means the cortex of gyrus without tuber involvement (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>The distribution of contacts with FRs in different parts of tubers (<sup>&#x2217;&#x2217;</sup><italic>P</italic> &#x003C; 0.01, the data in this group compared with the data of contacts without FRs and data of contacts with low FR rates. <sup><italic>a</italic></sup>The ratio of the high FR rate was more than 0.5). The figure shows distribution of FRs across different parts of the tuber. The majority of the high FR rate (ratio of occurrence frequency of fast ripples &#x2267;0.5) presented in the junction area of the tubers.</p></caption>
<graphic xlink:href="fnhum-15-680295-g001.tif"/>
</fig>
</sec>
<sec id="S3.SS5">
<title>Surgical Approaches and Postoperative Medical Treatments</title>
<p>Patients underwent either lobectomies or tuber resections. Tuber resections were used for epileptogenic tubers within or close to eloquent areas. Lobectomies were applied when epileptogenic tubers were in the anterior temporal lobe or the frontal pole. Multiple tuber resections or lobectomies with tuber resection were considered in cases of multiple epileptogenic tubers unable to be removed by a single lobectomy. Pharmaceutical treatments were provided to all postoperative patients, utilizing optimized combinations of two to four kinds of antiseizure medications. Potential medications used in postoperative patient care were topiramate, vigabatrin, valproate, levetiracetam, lamotrigine, and oxcarbazepine.</p>
</sec>
<sec id="S3.SS6">
<title>Statistical Analysis</title>
<p>Statistical analysis was completed using the SPSS statistical program (version 19.0; SPSS, Inc., Chicago, IL, United States). Postoperative seizure controls were classified according to the Engel method into class I (seizure free), class II (rare seizures), class III (&#x003E;90% reduction in seizure frequency), and class IV (&#x003C;90 reduction in seizure frequency). Outcomes were described with percentages, means, and SD. Univariate analysis of categorical variables was performed using &#x03C7;<sup>2</sup> and Fisher exact tests. <italic>t</italic>-tests and <italic>F</italic>-tests were used for comparison of continuous variables. When the two-tailed error probability <italic>P</italic> was less than 0.05, the outcome was considered to be significant.</p>
</sec>
</sec>
<sec id="S4">
<title>Results</title>
<sec id="S4.SS1">
<title>Patients and Presurgical Evaluations</title>
<p>A total of 46 patients with TSC underwent epilepsy surgery at our hospitals from January 2016 to December 2018. Twenty-one patients received implanted SEEG electrodes and underwent resective surgery, and 17 of them with comprehensive FRs data were included in this study (<xref ref-type="table" rid="T1">Table 1</xref>). Both female (<italic>n</italic> = 6) and male (<italic>n</italic> = 11) patients were presented. Patient ages ranged from 2.9 to 12.6 (mean = 6.13 &#x00B1; 3.06) years. Types of clinical seizures at onset included generalized epileptic spasms (<italic>n</italic> = 9), generalized tonic&#x2013;clonic seizure (<italic>n</italic> = 3), focal seizure (<italic>n</italic> = 4), and generalized clonic seizure (<italic>n</italic> = 1). Seizure frequencies included either daily seizures (<italic>n</italic> = 14) or weekly seizures (<italic>n</italic> = 3). Age at seizure onset ranged from 0.2 to 5.9 (mean = 1.34 &#x00B1; 1.60) years. The durations of preoperative seizures ranged from 2.3 to 9.6 (mean = 4.79 &#x00B1; 2.37) years. Through observation and counting, each patient had 10.18 &#x00B1; 3.21 (range = 4&#x2013;16) cortical tubers.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Patients&#x2019; clinical and demographic characteristics and FR data.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"><bold>No.</bold></td>
<td valign="top" align="center"><bold>Gender</bold></td>
<td valign="top" align="center"><bold>Age at operation (years)</bold></td>
<td valign="top" align="center"><bold>Age at seizure onset (years)</bold></td>
<td valign="top" align="center"><bold>Seizure type</bold></td>
<td valign="top" align="center"><bold>Drugs</bold></td>
<td valign="top" align="center"><bold>Number of tubers</bold></td>
<td valign="top" align="center"><bold>Number of electrodes</bold></td>
<td valign="top" align="center"><bold>Number of tubers covered with SEEG</bold></td>
<td valign="top" align="center"><bold>Total number of contacts</bold></td>
<td valign="top" align="center"><bold>Contacts containing FRs (%)</bold></td>
<td valign="top" align="center"><bold>Number of FRs in contacts containing FRs (mean &#x00B1; SD)</bold></td>
<td valign="top" align="center"><bold>Tubers with FRs (%)</bold></td>
<td valign="top" align="center"><bold>Onset tuber</bold></td>
<td valign="top" align="center"><bold>Propagating tuber</bold></td>
<td valign="top" align="center"><bold>Resected tubers</bold></td>
<td valign="top" align="center"><bold>Follow-up (years)</bold></td>
<td valign="top" align="center"><bold>Seizure free at 1 year</bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">8.2</td>
<td valign="top" align="center">5.9</td>
<td valign="top" align="center">GCTS CPS</td>
<td valign="top" align="center">VPA/LMT</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">52</td>
<td valign="top" align="center">8 (15.4)</td>
<td valign="top" align="center">125.63 &#x00B1; 122.39</td>
<td valign="top" align="center">3 (75.0)</td>
<td valign="top" align="center">R-T</td>
<td valign="top" align="center">R-P R-F</td>
<td valign="top" align="center">R-T R-F</td>
<td valign="top" align="center">3.7</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">CPS Tonic</td>
<td valign="top" align="center">OXC/LEV LMT/VPA</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">127</td>
<td valign="top" align="center">6 (4.7)</td>
<td valign="top" align="center">34.33 &#x00B1; 37.25</td>
<td valign="top" align="center">3 (33.3)</td>
<td valign="top" align="center">L-F L-T</td>
<td valign="top" align="center">L-T L-O</td>
<td valign="top" align="center">L-T/L-F L-O</td>
<td valign="top" align="center">3.3</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">5.8</td>
<td valign="top" align="center">0.8</td>
<td valign="top" align="center">Spasm GTCS/AA</td>
<td valign="top" align="center">VAP/LMT TMP</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">128</td>
<td valign="top" align="center">47 (36.7)</td>
<td valign="top" align="center">41.32 &#x00B1; 74.50</td>
<td valign="top" align="center">10 (90.9)</td>
<td valign="top" align="center">R- R-F</td>
<td valign="top" align="center">R-FP R-TO</td>
<td valign="top" align="center">R-F/R-FP R-T/R-TO</td>
<td valign="top" align="center">2.7</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">2.6</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">Spasm CPS</td>
<td valign="top" align="center">VPA/LMT LEV/RPM</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center">17 (16.3)</td>
<td valign="top" align="center">9.35 &#x00B1; 19.36</td>
<td valign="top" align="center">6 (75.0)</td>
<td valign="top" align="center">R-P</td>
<td valign="top" align="center">R-T R-PC</td>
<td valign="top" align="center">R-P/R-PC R-T</td>
<td valign="top" align="center">2.6</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">3.8</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">Spasm GTCS</td>
<td valign="top" align="center">VPA/LEV VGB/RPM</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">122</td>
<td valign="top" align="center">14 (11.5)</td>
<td valign="top" align="center">6.07 &#x00B1; 3.67</td>
<td valign="top" align="center">5 (45.5)</td>
<td valign="top" align="center">L-F R-F</td>
<td valign="top" align="center">L-FP L-T L-F</td>
<td valign="top" align="center">L-FP L-T/L-F</td>
<td valign="top" align="center">2.3</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">3.7</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">Spasm CPS</td>
<td valign="top" align="center">VPA/LEV RPM/VGB</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">126</td>
<td valign="top" align="center">3 (2.4)</td>
<td valign="top" align="center">3.33 &#x00B1; 2.31</td>
<td valign="top" align="center">2 (18.2)</td>
<td valign="top" align="center">R-P</td>
<td valign="top" align="center">R-I R-T</td>
<td valign="top" align="center">R-T/R-P R-I</td>
<td valign="top" align="center">1.8</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">4.3</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">Spasm tonic</td>
<td valign="top" align="center">VPA/CLB RPM/VGB</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">121</td>
<td valign="top" align="center">26 (21.5)</td>
<td valign="top" align="center">28.50 &#x00B1; 55.07</td>
<td valign="top" align="center">7 (58.3)</td>
<td valign="top" align="center">R-T</td>
<td valign="top" align="center">R-F</td>
<td valign="top" align="center">R-T R-F</td>
<td valign="top" align="center">1.7</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">8.1</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">CPS GTCS</td>
<td valign="top" align="center">VPA/LMT RPM</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">124</td>
<td valign="top" align="center">33 (26.6)</td>
<td valign="top" align="center">55.61 &#x00B1; 80.61</td>
<td valign="top" align="center">8 (88.9)</td>
<td valign="top" align="center">L-P</td>
<td valign="top" align="center">L-T L-PC</td>
<td valign="top" align="center">L-P/L-PC L-T</td>
<td valign="top" align="center">1.6</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">3.8</td>
<td valign="top" align="center">0.8</td>
<td valign="top" align="center">Clonic/AA GCTS</td>
<td valign="top" align="center">VPA/TMP LEV</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">28 (24.1)</td>
<td valign="top" align="center">32.61 &#x00B1; 21.86</td>
<td valign="top" align="center">7 (87.5)</td>
<td valign="top" align="center">R-F R-T</td>
<td valign="top" align="center">R-I R-FC</td>
<td valign="top" align="center">R-F/R-FC R-T/R-I</td>
<td valign="top" align="center">1.3</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">Spasm GCTS</td>
<td valign="top" align="center">LEV/TMP VGB/LMT</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">127</td>
<td valign="top" align="center">24 (18.9)</td>
<td valign="top" align="center">157.42 &#x00B1; 171.45</td>
<td valign="top" align="center">4 (40)</td>
<td valign="top" align="center">R-F</td>
<td valign="top" align="center">L-F R-T</td>
<td valign="top" align="center">R-F/L-F</td>
<td valign="top" align="center">1.2</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">11</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">6.6</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">CPS/tonic GTCS</td>
<td valign="top" align="center">VPA/CBZ VGB/RPM</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">126</td>
<td valign="top" align="center">34 (27.0)</td>
<td valign="top" align="center">100.09 &#x00B1; 170.57</td>
<td valign="top" align="center">8 (88.9)</td>
<td valign="top" align="center">L-F</td>
<td valign="top" align="center">L-P L-T</td>
<td valign="top" align="center">L-F/L-P L-T</td>
<td valign="top" align="center">1.1</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">12</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">CPS GTCS</td>
<td valign="top" align="center">CBZ/VPA LMT</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">90</td>
<td valign="top" align="center">43 (47.8)</td>
<td valign="top" align="center">108.52 &#x00B1; 218.28</td>
<td valign="top" align="center">6 (100)</td>
<td valign="top" align="center">L-P</td>
<td valign="top" align="center">L-F L-I</td>
<td valign="top" align="center">L-P/L-F L-I</td>
<td valign="top" align="center">1.1</td>
<td valign="top" align="center">Yes</td>
</tr>
<tr>
<td valign="top" align="left">13</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">4.8</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">Spasm CPS</td>
<td valign="top" align="center">OXC/VPA VGB/RPM</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center">51 (49.4)</td>
<td valign="top" align="center">77.16 &#x00B1; 73.16</td>
<td valign="top" align="center">7 (100)</td>
<td valign="top" align="center">R-F L-F</td>
<td valign="top" align="center">R-T/R-P R-FC</td>
<td valign="top" align="center">R-F/R-T R-P/R-FC</td>
<td valign="top" align="center">2.9</td>
<td valign="top" align="center">No</td>
</tr>
<tr>
<td valign="top" align="left">14</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">10.8</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">GTSC myoclonic</td>
<td valign="top" align="center">LEV/LMT VPA/RPM</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">4 (3.4)</td>
<td valign="top" align="center">4.75 &#x00B1; 3.59</td>
<td valign="top" align="center">3 (30)</td>
<td valign="top" align="center">L-T</td>
<td valign="top" align="center">L-O/L-P</td>
<td valign="top" align="center">L-T/L-O L-P</td>
<td valign="top" align="center">2.8</td>
<td valign="top" align="center">No</td>
</tr>
<tr>
<td valign="top" align="left">15</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">4.2</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">Spasm tonic AA</td>
<td valign="top" align="center">VPA/OXC LMT/VGB RPM</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">124</td>
<td valign="top" align="center">18 (14.5)</td>
<td valign="top" align="center">50.61 &#x00B1; 41.78</td>
<td valign="top" align="center">6 (75.0)</td>
<td valign="top" align="center">R-Central R-F</td>
<td valign="top" align="center">R-F/L-F R-C</td>
<td valign="top" align="center">R-F R-Central R-C</td>
<td valign="top" align="center">1.8</td>
<td valign="top" align="center">No</td>
</tr>
<tr>
<td valign="top" align="left">16</td>
<td valign="top" align="center">Female</td>
<td valign="top" align="center">12.6</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">GCTS CPS</td>
<td valign="top" align="center">LEV/VGB VPA</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">110</td>
<td valign="top" align="center">53 (48.2)</td>
<td valign="top" align="center">25.45 &#x00B1; 38.33</td>
<td valign="top" align="center">7 (77.8)</td>
<td valign="top" align="center">R-F L-P</td>
<td valign="top" align="center">R-T/R-I R-TO</td>
<td valign="top" align="center">R-F/R-I R-T R-TO</td>
<td valign="top" align="center">1.7</td>
<td valign="top" align="center">No</td>
</tr>
<tr>
<td valign="top" align="left">17</td>
<td valign="top" align="center">Male</td>
<td valign="top" align="center">2.9</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">Spasm tonic</td>
<td valign="top" align="center">LEV/CLB RPM/VGB</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">127</td>
<td valign="top" align="center">62 (48.8)</td>
<td valign="top" align="center">11.63 &#x00B1; 22.39</td>
<td valign="top" align="center">10 (90.9)</td>
<td valign="top" align="center">L-F R-P</td>
<td valign="top" align="center">L-I/L-C</td>
<td valign="top" align="center">L-F/L-I L-C</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">No</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>AA, atypical absence; C, cingulate gyrus; CPS, complex partial seizure; F, frontal lobe; GTCS, generalized tonic-clonic seizure; I, insular lobe; L, left; NA, no available; O, occipital lobe; P, parietal lobe; R, right; T, temporal lobe; CBZ, carbamazepine; CLB, clobazam; LEV, levetiracetam; LMT, lamotrigine; OXC, oxcarbazepine; RPM, rapamycin; TMP, topiramate; VGB, vigabatrin; VPA, valproate.</italic></attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S4.SS2">
<title>Surgical Approaches and Outcomes</title>
<p>A total of 25 epileptogenic tubers were identified across all patients. Patients were observed to have a single epileptogenic tuber (<italic>n</italic> = 9) or two epileptogenic tubers (<italic>n</italic> = 8); no patient was observed to have more than two epileptogenic tubers. Furthermore, 35 early propagating tubers were identified. Surgical interventions varied case by case and included epileptogenic tuber resection (<italic>n</italic> = 6), lobectomy or multilobar resection (<italic>n</italic> = 7), and a combination of lobectomy and tuber resection (<italic>n</italic> = 4). In total, 52 tubers, including 22 epileptogenic tubers and 30 propagating tubers, were removed. At 1-year follow-up, 12 patients (70.6%) achieved seizure freedom (Engel I), one reached Engel II, and the other four cases reached Engel III&#x2013;IV seizure control. Significant difference was found in the percentage of total removal of epileptogenic tubers between patients with postoperative seizure freedom and those with postoperative continuous seizure at 1-year follow-up (<italic>P</italic> = 0.0239) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Influence factors of postoperative seizure freedom.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"><bold>Factors</bold></td>
<td valign="top" align="left"><bold>Patients with seizure freedom (<italic>n</italic> = 12)</bold></td>
<td valign="top" align="left"><bold>Patients with continuous seizure (<italic>n</italic> = 5)</bold></td>
<td valign="top" align="left"><bold><italic>P</italic>-value</bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age at surgery (years)</td>
<td valign="top" align="left">5.53 + 2.49</td>
<td valign="top" align="left">7.06 + 4.34</td>
<td valign="top" align="left">0.3675</td>
</tr>
<tr>
<td valign="top" align="left">History of seizure (years)</td>
<td valign="top" align="left">4.63 + 2.21</td>
<td valign="top" align="left">5.80 + 3.20</td>
<td valign="top" align="left">0.3954</td>
</tr>
<tr>
<td valign="top" align="left">Age at first seizure (years)</td>
<td valign="top" align="left">1.37 + 1.79</td>
<td valign="top" align="left">1.26 + 1.19</td>
<td valign="top" align="left">0.9021</td>
</tr>
<tr>
<td valign="top" align="left">Patients with epileptic spasm (count/%)</td>
<td valign="top" align="left">6/50.0%</td>
<td valign="top" align="left">3/60.0%</td>
<td valign="top" align="left">0.8754</td>
</tr>
<tr>
<td valign="top" align="left">Patients with partial seizure (count/%)</td>
<td valign="top" align="left">7/58.3%</td>
<td valign="top" align="left">2/40.0%</td>
<td valign="top" align="left">0.7066</td>
</tr>
<tr>
<td valign="top" align="left">Number of cortical tubers</td>
<td valign="top" align="left">9.50 + 3.73</td>
<td valign="top" align="left">10.6 + 3.27</td>
<td valign="top" align="left">0.5758</td>
</tr>
<tr>
<td valign="top" align="left">Number of epileptogenic tubers</td>
<td valign="top" align="left">1.33 + 0.49</td>
<td valign="top" align="left">1.80 + 0.45</td>
<td valign="top" align="left">0.0855</td>
</tr>
<tr>
<td valign="top" align="left">Number of propagating tubers</td>
<td valign="top" align="left">2.00 + 0.43</td>
<td valign="top" align="left">2.40 + 0.55</td>
<td valign="top" align="left">0.1269</td>
</tr>
<tr>
<td valign="top" align="left">Number of epileptogenic tubers and early propagating tubers</td>
<td valign="top" align="left">3.33 + 0.78</td>
<td valign="top" align="left">4.20 + 0.84</td>
<td valign="top" align="left">0.0580</td>
</tr>
<tr>
<td valign="top" align="left">Number of removed tubers</td>
<td valign="top" align="left">2.92 + 0.67</td>
<td valign="top" align="left">3.40 + 0.55</td>
<td valign="top" align="left">0.1794</td>
</tr>
<tr>
<td valign="top" align="left">Total removal of epileptogenic tubers (count/%)</td>
<td valign="top" align="left">12/100%</td>
<td valign="top" align="left">2/40%</td>
<td valign="top" align="left"><bold>0.0239</bold></td>
</tr>
<tr>
<td valign="top" align="left">Total removal of epileptogenic and early propagating tubers (count/%)</td>
<td valign="top" align="left">9/75%</td>
<td valign="top" align="left">1/20%</td>
<td valign="top" align="left">0.1191</td>
</tr>
<tr>
<td valign="top" align="left">Percentage of contacts with fast ripples (%)</td>
<td valign="top" align="left">21.01 + 12.80</td>
<td valign="top" align="left">32.86 + 22.18</td>
<td valign="top" align="left">0.1806</td>
</tr>
<tr>
<td valign="top" align="left">Percentage of tubers with fast ripples (%)</td>
<td valign="top" align="left">67.55 &#x00B1; 27.74</td>
<td valign="top" align="left">74.74 + 26.97</td>
<td valign="top" align="left">0.6309</td>
</tr>
<tr>
<td valign="top" align="left">Number of contacts with fast ripples</td>
<td valign="top" align="left">23.58 + 14.33</td>
<td valign="top" align="left">37.60 + 25.12</td>
<td valign="top" align="left">0.1609</td>
</tr>
<tr>
<td valign="top" align="left">Number of tubers with fast ripples</td>
<td valign="top" align="left">5.75 + 2.42</td>
<td valign="top" align="left">6.60 + 2.51</td>
<td valign="top" align="left">0.5235</td>
</tr>
<tr>
<td valign="top" align="left">Total resection of contacts with high fast ripples rate (FRs rate &#x2265; 0.5)</td>
<td valign="top" align="left">11 (91.7%)</td>
<td valign="top" align="left">0 (0.0%)</td>
<td valign="top" align="left"><bold>0.0023</bold></td>
</tr>
<tr>
<td valign="top" align="left">Total resection of tubers with high fast ripples rate (FRs rate &#x2265; 0.5)</td>
<td valign="top" align="left">11 (91.7%)</td>
<td valign="top" align="left">0 (0.0%)</td>
<td valign="top" align="left"><bold>0.0023</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>Bold values indicate the <italic>P</italic> &#x003C; 0.05.</italic></attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S4.SS3">
<title>Interictal FRs and the Distribution</title>
<p>There were 471 (24.2%) FR contacts detected from the 1,944 contacts of 144 implanted SEEG electrodes, including 75 (3.9%) high FR rate contacts. Moreover, 102 (67.1%) FR tubers were observed across all covered tubers (<italic>n</italic> = 152) in all patients (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>The occurrence frequency of FR discharge significantly varied across the tuber anatomy (<italic>P</italic> &#x003C; 0.01). There were 62.7% (47 of 75) high FR rate contacts located at the junction region of the tubers, and those contacts without FRs mainly located out of the tubers (<italic>n</italic> = 703, 47.7% of 1,473). High FR rate contacts included two (0.2% of 834) contacts out of the tubers, 47 (8.4% of 561) contacts in the junction region of the tubers, and 26 (4.7% of 549) contacts in the inner of the tubers (<xref ref-type="fig" rid="F1">Figure 1</xref>). There were significant differences in the percentage of the high FR rate contacts in the three parts of cortical tubers (<italic>P</italic> = 0.0000).</p>
</sec>
<sec id="S4.SS4">
<title>Interictal FRs and Seizure Control</title>
<p>The tubers and contacts with FRs were compared between patients with Engel I seizure controls and those with Engel II&#x2013;IV seizure controls. There was no significant difference found in percentage (or number) of FR contacts (or tubers) between those two groups (<italic>P</italic> &#x003E; 0.05) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>The removed brain tissues included 272 FR contacts (<xref ref-type="fig" rid="F2">Figure 2</xref>) and 48 FR tubers (<xref ref-type="fig" rid="F3">Figure 3</xref>) in all patients. Each patient removed 3&#x2013;30 FR contacts, and the maximum rates of FRs occurrence frequency in remained contacts ranged from 0 to 1 in different cases (<xref ref-type="fig" rid="F2">Figure 2</xref>). Significant differences were found in seizure freedom between patients who totally removed the high FR rate contacts and those who partially removed the high FR rate contacts (100 vs. 16.7%, <italic>P</italic> &#x003C; 0.05) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Resective range of contacts with FRs in all of the 17 patients. This figure shows the removed contacts with FRs in each patient. There were 272 FR contacts removed in total. White bars show the reserved contacts with FR discharges. Color bars show the removed contacts with FRs. The same color bars in each patient meant the removed contacts in the same electrode, whereas the different color bars in each patient meant the contacts from different electrodes. Patients 13&#x2013;17 suffered continuous seizure attack after resective operations. <italic>y-</italic>axis was the ratio of FRs on each contact. <italic>x-</italic>axis was contacts in order of the ratio of FR discharges in each patient.</p></caption>
<graphic xlink:href="fnhum-15-680295-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Resective range of the tubers with FRs in all of the 17 patients. This figure shows the removed fast ripple tubers in each patient, and the number was 48 in total. White bars show the reserved tubers with FR discharges. Color bars show the removed tubers with FRs, and different color bars meant different removed tubers in each patient. Patients 13&#x2013;17 suffered continuous seizure attack after resective operations. <italic>y</italic>-axis was the ratio of FRs on each tuber. <italic>x-</italic>axis was tubers in order of the ratio of FRs in different tubers in each patient.</p></caption>
<graphic xlink:href="fnhum-15-680295-g003.tif"/>
</fig>
<p>Each patient removed two to four FR tubers, and the maximum FR rate in the remained tubers ranged from none to one in different cases (<xref ref-type="fig" rid="F3">Figure 3</xref>). Significant differences were found in seizure freedom between those who totally removed high FR rate tubers and cases who partially removed high FR rate tubers (100 vs. 16.7%, <italic>P</italic> &#x003C; 0.05) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
</sec>
<sec id="S4.SS5">
<title>Complications</title>
<p>One patient presented asymptomatic epidural hematoma around an electrode. No complication was identified during FR recording.</p>
</sec>
</sec>
<sec id="S5">
<title>Discussion</title>
<p>To the best of our knowledge, this study presented the first comprehensive observations of FRs detected by SEEG in cortical tubers of TSC patients. FRs were recorded in 24.2% of SEEG contacts and 67.1% of tubers covered with SEEG electrodes. The occurrence frequency of FRs varied among patients. However, areas with FRs were relatively stable in the same patient, which was consistent with previous studies (<xref ref-type="bibr" rid="B30">Bagshaw et al., 2009</xref>).</p>
<p><xref ref-type="bibr" rid="B25">Fujiwara et al. (2016)</xref> and <xref ref-type="bibr" rid="B24">Okanishi et al. (2014)</xref> reported the presence of ictal and interictal ripples and FRs in children with TSC recorded by subdural intracranial EEG, respectively. However, the analysis of ictal HFOs was unreliable because of various potential impacts, and the ripples could not work as a biomarker for epileptogenic onset zone (<xref ref-type="bibr" rid="B17">Cr&#x00E9;pon et al., 2010</xref>; <xref ref-type="bibr" rid="B22">Akiyama et al., 2011</xref>; <xref ref-type="bibr" rid="B20">Fedele et al., 2019</xref>). <xref ref-type="bibr" rid="B25">Fujiwara et al. (2016)</xref> found that complete resection of regions with HFOs led to a better surgical outcome. However, our study and the study by <xref ref-type="bibr" rid="B24">Okanishi et al. (2014)</xref> showed that extensive FRs were recorded in TSC patients, and complete resection of FR contact was uncommon, especially for patients with multiple tubers. Therefore, high FR rate contacts should be identified.</p>
<p>Clinicians faced multifaceted challenges related to thresholds and the identification of potential epileptogenic areas. <xref ref-type="bibr" rid="B24">Okanishi et al. (2014)</xref> applied a bootstrapping method for thresholding, which yielded a mean HFO rate and then used it to distinguish between high and low FR channels. Application of this method led to a significant correlation between removal of the high occurrence frequency FR channels and the postoperative seizure freedom in TSC patients with subdural electrode EEG. In this retrospective research, we used 0.5 as the cutoff ratio of high occurrence frequency of FRs to define the epileptogenic zone and tubers, which had been used by <xref ref-type="bibr" rid="B29">Burnos et al. (2014)</xref>. Then, we found significant differences in seizure freedom between patients who totally removed contacts (tubers) with high FR rates and those who partially removed, which indicated that the threshold of 0.5 had practicability and reliability in the identification of epileptogenic tuber in TSC patients, but more data were still needed to test and verify.</p>
<p>Previously, the onset zones of TSC, localizing to TSC tuber itself vs. perituber cortex, were controversial (<xref ref-type="bibr" rid="B32">Ma et al., 2012</xref>; <xref ref-type="bibr" rid="B31">Kannan et al., 2016</xref>). TSC cortical tubers were observed to have dysmorphic cytomegalic and immature neurons, which played an important role in the generation and propagation of epileptic discharges (<xref ref-type="bibr" rid="B33">Abdijadid et al., 2015</xref>; <xref ref-type="bibr" rid="B34">M&#x00FC;hlebner et al., 2016</xref>). The perituber cortex was identified through abnormalities obtained through electrocorticography, diffusive tension image, histological pathology, immunohistochemical analysis, or molecular patterns (<xref ref-type="bibr" rid="B35">Oh et al., 2011</xref>; <xref ref-type="bibr" rid="B32">Ma et al., 2012</xref>; <xref ref-type="bibr" rid="B36">Krsek et al., 2013</xref>). <xref ref-type="bibr" rid="B31">Kannan et al. (2016)</xref> found that focal seizures and interictal epileptiform discharges raised at the center of epileptogenic tubers and propagated into the tuber rim, perituber cortex, and other epileptogenic tubers. With the use of SEEG, but not subdural intracranial EEG, the FRs in the inner of the tubers and junction area of the tubers could be recorded. In this study, we found that 62.6% of the high FR rate contacts presented on the junction region of the tuber and adjacent cortex, while the contacts with low FR rates were almost evenly distributed in the inner of the tubers, the junction area of the tubers, and out of the tubers. Therefore, the junction area of epileptogenic tubers should be the epileptogenic zones in TSC patients.</p>
<p>There are some limitations to this study. First, patients with one to three cortical tubers were excluded, because the epileptogenic tuber and propagative tuber need to be defined at the same time. Second, TSC patients with three or more epileptogenic tubers were not enrolled in the study, because most of them were excluded from the resective operations. Third, the sample of enrolled subjects was small because of the low incidence of TSC.</p>
</sec>
<sec id="S6">
<title>Conclusion</title>
<p>In conclusion, FRs were extensively recorded in patients with TSC utilizing SEEG, and electrode contacts with high FR rates can be used to localize epileptogenic tubers. Furthermore, the junction areas of the tubers had most contacts with high FR rates and indicated the locations of epileptogenic zones.</p>
</sec>
<sec id="S7">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="S8">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of Fourth Medical Center, General Hospital of PLA. Written informed consent for participation was not provided because this study is a retrospective study and patients did not provide additional information or perform other treatments or examinations.</p>
</sec>
<sec id="S9">
<title>Author Contributions</title>
<p>SlL and SZ performed the operative and collected candidate information. LY, ShL, and XYu finished the EEG recording. XYa, YW, LY, TL, and SlL performed HFO analyses. SlL, ShL, YW, and XYa drafted the manuscript. YW, LY, SZ, and TL analyzed the datasets. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a shared affiliation with several of the authors (YW, LY, SZ, TL, and SlL) at the time of review.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This research was supported by National Natural Science Foundation of China (81771388 and 82071448, SlL) and Beijing Nature and Science Foundation of China (7202045, SlL). Those funds did not involve the study design, data collection and analysis, interpretation of data and the writing of the report.</p>
</fn>
</fn-group>
<ack>
<p>The authors would like to show gratitude to the patients and their families for their long-term cooperation. The authors also appreciate the contribution provided by the following people: J. F. Cui from Neurosurgery Department, N. Liu, X. Y. Shang and all technicians in the Neurophysiologic Laboratory of Capital Epilepsy Therapy Center.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kingswood</surname> <given-names>J. C.</given-names></name> <name><surname>Bruzzi</surname> <given-names>P.</given-names></name> <name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>de Vries</surname> <given-names>P. J.</given-names></name> <name><surname>Fladrowski</surname> <given-names>C.</given-names></name> <name><surname>Hertzberg</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.</article-title> <source><italic>Orphanet J. Rare Dis</italic>.</source> <volume>9</volume>:<fpage>182</fpage>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname> <given-names>P.</given-names></name> <name><surname>Maria</surname> <given-names>B. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Tuberous sclerosis.</article-title> <source><italic>Handb. Clin. Neurol</italic>.</source> <volume>111</volume> <fpage>323</fpage>&#x2013;<lpage>331</lpage>.</citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>J.</given-names></name> <name><surname>Yu</surname> <given-names>X.</given-names></name> <name><surname>Liang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Hu</surname> <given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>First five generations Chinese family of tuberous scleroses complex due to a new mutation of the TSC1 gene.</article-title> <source><italic>J. Clin. Neurosci</italic>.</source> <volume>54</volume> <fpage>39</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2018.05.007</pub-id> <pub-id pub-id-type="pmid">29803333</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>T.</given-names></name> <name><surname>Guan</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>K.</given-names></name> <name><surname>Ding</surname> <given-names>P.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China.</article-title> <source><italic>Brain</italic></source> <volume>143</volume> <fpage>570</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awz411</pub-id> <pub-id pub-id-type="pmid">31953931</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Cui</surname> <given-names>Z.</given-names></name> <name><surname>Cui</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Long-term outcomes of epilepsy surgery in tuberous sclerosis complex.</article-title> <source><italic>J. Neurol.</italic></source> <volume>264</volume> <fpage>1146</fpage>&#x2013;<lpage>1154</lpage>.</citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Overwater</surname> <given-names>I. E.</given-names></name> <name><surname>Bindels-de Heus</surname> <given-names>K.</given-names></name> <name><surname>Rietman</surname> <given-names>A. B.</given-names></name> <name><surname>Ten Hoopen</surname> <given-names>L. W.</given-names></name> <name><surname>Vergouwe</surname> <given-names>Y.</given-names></name> <name><surname>Moll</surname> <given-names>H. A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs.</article-title> <source><italic>Epilepsia</italic></source> <volume>56</volume> <fpage>1239</fpage>&#x2013;<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13050</pub-id> <pub-id pub-id-type="pmid">26046563</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname> <given-names>D. A.</given-names></name> <name><surname>Wilfong</surname> <given-names>A. A.</given-names></name> <name><surname>Holland-Bouley</surname> <given-names>K.</given-names></name> <name><surname>Anderson</surname> <given-names>A. E.</given-names></name> <name><surname>Agricola</surname> <given-names>K.</given-names></name> <name><surname>Tudor</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>74</volume> <fpage>679</fpage>&#x2013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23960</pub-id> <pub-id pub-id-type="pmid">23798472</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Lee</surname> <given-names>E. J.</given-names></name> <name><surname>Eom</surname> <given-names>S.</given-names></name> <name><surname>Kang</surname> <given-names>H. C.</given-names></name> <name><surname>Lee</surname> <given-names>J. S.</given-names></name> <name><surname>Kim</surname> <given-names>H. D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Ketogenic diet for the management of epilepsy associated with tuberous sclerosis complex in children.</article-title> <source><italic>J. Epilepsy. Res.</italic></source> <volume>7</volume> <fpage>45</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.14581/jer.17008</pub-id> <pub-id pub-id-type="pmid">28775955</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname> <given-names>F. E.</given-names></name> <name><surname>Van Huffelen</surname> <given-names>A. C.</given-names></name> <name><surname>Algra</surname> <given-names>A.</given-names></name> <name><surname>van Nieuwenhuizen</surname> <given-names>O.</given-names></name></person-group> (<year>2007</year>). <article-title>Epilepsy surgery in tuberous sclerosis: a systematic review.</article-title> <source><italic>Epilepsia</italic></source> <volume>48</volume> <fpage>1477</fpage>&#x2013;<lpage>1484</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01117.x</pub-id> <pub-id pub-id-type="pmid">17484753</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fallah</surname> <given-names>A.</given-names></name> <name><surname>Guyatt</surname> <given-names>G. H.</given-names></name> <name><surname>Snead</surname> <given-names>O. C.</given-names> <suffix>III</suffix></name> <name><surname>Ebrahim</surname> <given-names>S.</given-names></name> <name><surname>Ibrahim</surname> <given-names>G. M.</given-names></name> <name><surname>Mansouri</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Predictors of Seizure Outcomes in Children with Tuberous Sclerosis Complex and Intractable Epilepsy Undergoing Resective Epilepsy Surgery: an Individual Participant Data Meta-Analysis.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<fpage>e53565</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0053565</pub-id> <pub-id pub-id-type="pmid">23405072</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>X.</given-names></name> <name><surname>Ding</surname> <given-names>P.</given-names></name> <name><surname>Yuan</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Liang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Cortico-Cortical Evoked Potentials in Children With Tuberous Sclerosis Complex Using Stereo-Electroencephalography.</article-title> <source><italic>Front. Neurol.</italic></source> <volume>10</volume>:<fpage>1093</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2019.01093</pub-id> <pub-id pub-id-type="pmid">31736846</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>K.</given-names></name> <name><surname>Cui</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Jiang</surname> <given-names>T.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Cong</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Magnetic resonance imaging of tuberous sclerosis complex with or without epilepsy at 7 T.</article-title> <source><italic>Neuroradiology</italic></source> <volume>60</volume> <fpage>785</fpage>&#x2013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1007/s00234-018-2040-2</pub-id> <pub-id pub-id-type="pmid">29869697</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yogi</surname> <given-names>A.</given-names></name> <name><surname>Hirata</surname> <given-names>Y.</given-names></name> <name><surname>Karavaeva</surname> <given-names>E.</given-names></name> <name><surname>Harris</surname> <given-names>R. J.</given-names></name> <name><surname>Wu</surname> <given-names>J. Y.</given-names></name> <name><surname>Yudovin</surname> <given-names>S. L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex.</article-title> <source><italic>Neurology</italic></source> <volume>85</volume> <fpage>2011</fpage>&#x2013;<lpage>2015</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000002202</pub-id> <pub-id pub-id-type="pmid">26546629</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kargiotis</surname> <given-names>O.</given-names></name> <name><surname>Lascano</surname> <given-names>A. M.</given-names></name> <name><surname>Garibotto</surname> <given-names>V.</given-names></name> <name><surname>Spinelli</surname> <given-names>L.</given-names></name> <name><surname>Genetti</surname> <given-names>M.</given-names></name> <name><surname>Wissmeyer</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Localization of the epileptogenic tuber with electric source imaging in patients with tuberous sclerosis.</article-title> <source><italic>Epilepsy Res.</italic></source> <volume>108</volume> <fpage>267</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2013.11.003</pub-id> <pub-id pub-id-type="pmid">24315017</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chugani</surname> <given-names>H. T.</given-names></name> <name><surname>Luat</surname> <given-names>A. F.</given-names></name> <name><surname>Kumar</surname> <given-names>A.</given-names></name> <name><surname>Govindan</surname> <given-names>R.</given-names></name> <name><surname>Pawlik</surname> <given-names>K.</given-names></name> <name><surname>Asano</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>&#x03B1;-[11C]-Methyl-L-tryptophan&#x2013;PET in 191 patients with tuberous sclerosis complex.</article-title> <source><italic>Neurology</italic></source> <volume>81</volume> <fpage>674</fpage>&#x2013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0b013e3182a08f3f</pub-id> <pub-id pub-id-type="pmid">23851963</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname> <given-names>J.</given-names></name> <name><surname>LeVan</surname> <given-names>P.</given-names></name> <name><surname>Chander</surname> <given-names>R.</given-names></name> <name><surname>Hall</surname> <given-names>J.</given-names></name> <name><surname>Dubeau</surname> <given-names>F.</given-names></name> <name><surname>Gotman</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Interictal high-frequency oscillations (80-500 Hz) are an indicator of seizure onset areas independent of spikes in the human epileptic brain.</article-title> <source><italic>Epilepsia</italic></source> <volume>49</volume> <fpage>1893</fpage>&#x2013;<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01656.x</pub-id> <pub-id pub-id-type="pmid">18479382</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cr&#x00E9;pon</surname> <given-names>B.</given-names></name> <name><surname>Navarro</surname> <given-names>V.</given-names></name> <name><surname>Hasboun</surname> <given-names>D.</given-names></name> <name><surname>Clemenceau</surname> <given-names>S.</given-names></name> <name><surname>Martinerie</surname> <given-names>J.</given-names></name> <name><surname>Baulac</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Le Van Quyen M. et al. Mapping interictal oscillations greater than 200 Hz recorded with intracranial macroelectrodes in human epilepsy.</article-title> <source><italic>Brain</italic></source> <volume>133</volume> <fpage>33</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp277</pub-id> <pub-id pub-id-type="pmid">19920064</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fedele</surname> <given-names>T.</given-names></name> <name><surname>Burnos</surname> <given-names>S.</given-names></name> <name><surname>Boran</surname> <given-names>E.</given-names></name> <name><surname>Krayenb&#x00FC;hl</surname> <given-names>N.</given-names></name> <name><surname>Hilfiker</surname> <given-names>P.</given-names></name> <name><surname>Grunwald</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Resection of high frequency oscillations predicts seizure outcome in the individual patient.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>7</volume>:<fpage>13836</fpage>.</citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname> <given-names>J.</given-names></name> <name><surname>Zijlmans</surname> <given-names>M.</given-names></name> <name><surname>Zelmann</surname> <given-names>R.</given-names></name> <name><surname>Olivier</surname> <given-names>A.</given-names></name> <name><surname>Hall</surname> <given-names>J.</given-names></name> <name><surname>Gotman</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Value of electrical stimulation and high frequency oscillations (80-500 Hz) in identifying epileptogenic areas during intracranial EEG recordings.</article-title> <source><italic>Epilepsia</italic></source> <volume>51</volume> <fpage>573</fpage>&#x2013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02389.x</pub-id> <pub-id pub-id-type="pmid">19845730</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fedele</surname> <given-names>T.</given-names></name> <name><surname>Ramantani</surname> <given-names>G.</given-names></name> <name><surname>Sarnthein</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>High frequency oscillations as markers of epileptogenic tissue - End of the party?</article-title>. <source><italic>Clin. Neurophysiol.</italic></source> <volume>130</volume> <fpage>624</fpage>&#x2013;<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinph.2019.01.016</pub-id> <pub-id pub-id-type="pmid">30870797</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haegelen</surname> <given-names>C.</given-names></name> <name><surname>Perucca</surname> <given-names>P.</given-names></name> <name><surname>Ch&#x00E2;tillon</surname> <given-names>C. E.</given-names></name> <name><surname>Andrade-Valen&#x00E7;a</surname> <given-names>L.</given-names></name> <name><surname>Zelmann</surname> <given-names>R.</given-names></name> <name><surname>Jacobs</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>High-frequency oscillations, extent of surgical resection, and surgical outcome in drug-resistant focal epilepsy.</article-title> <source><italic>Epilepsia</italic></source> <volume>54</volume> <fpage>848</fpage>&#x2013;<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12075</pub-id> <pub-id pub-id-type="pmid">23294353</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname> <given-names>T.</given-names></name> <name><surname>McCoy</surname> <given-names>B.</given-names></name> <name><surname>Go</surname> <given-names>C. Y.</given-names></name> <name><surname>Ochi</surname> <given-names>A.</given-names></name> <name><surname>Elliott</surname> <given-names>I. M.</given-names></name> <name><surname>Akiyama</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Focal resection of fast ripples on extraoperative intracranial EEG improves seizure outcome in pediatric epilepsy.</article-title> <source><italic>Epilepsia</italic></source> <volume>52</volume> <fpage>1802</fpage>&#x2013;<lpage>1811</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03199.x</pub-id> <pub-id pub-id-type="pmid">21801168</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>G. P.</given-names></name> <name><surname>Yan</surname> <given-names>J. Q.</given-names></name> <name><surname>Yu</surname> <given-names>Z. X.</given-names></name> <name><surname>Wang</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>X. N.</given-names></name> <name><surname>Mei</surname> <given-names>S. S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Automated detector of high frequency oscillations in epilepsy based on maximum distributed peak points.</article-title> <source><italic>Int. J. Neural. Sys.</italic></source> <volume>28</volume>:<fpage>1750029</fpage>. <pub-id pub-id-type="doi">10.1142/s0129065717500290</pub-id> <pub-id pub-id-type="pmid">28669244</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okanishi</surname> <given-names>T.</given-names></name> <name><surname>Akiyama</surname> <given-names>T.</given-names></name> <name><surname>Tanaka</surname> <given-names>S.</given-names></name> <name><surname>Mayo</surname> <given-names>E.</given-names></name> <name><surname>Mitsutake</surname> <given-names>A.</given-names></name> <name><surname>Boelman</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex.</article-title> <source><italic>Epilepsia</italic></source> <volume>55</volume> <fpage>1602</fpage>&#x2013;<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12761</pub-id> <pub-id pub-id-type="pmid">25196064</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname> <given-names>H.</given-names></name> <name><surname>Leach</surname> <given-names>J. L.</given-names></name> <name><surname>Greiner</surname> <given-names>H. M.</given-names></name> <name><surname>Holland-Bouley</surname> <given-names>K. D.</given-names></name> <name><surname>Rose</surname> <given-names>D. F.</given-names></name> <name><surname>Arthur</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Resection of ictal high frequency oscillations is associated withfavorable surgical outcome in pediatric drug resistant epilepsy secondary totuberous sclerosis complex.</article-title> <source><italic>Epilepsy Res.</italic></source> <volume>126</volume> <fpage>90</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2016.07.005</pub-id> <pub-id pub-id-type="pmid">27450371</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Northrup</surname> <given-names>H.</given-names></name> <name><surname>Krueger</surname> <given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.</article-title> <source><italic>Pediatr. Neurol.</italic></source> <volume>49</volume> <fpage>243</fpage>&#x2013;<lpage>254</lpage>.</citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>A.</given-names></name> <name><surname>Zhao</surname> <given-names>M.</given-names></name> <name><surname>Jiang</surname> <given-names>H.</given-names></name> <name><surname>Yu</surname> <given-names>S.</given-names></name> <name><surname>Meng</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology.</article-title> <source><italic>Epilepsia</italic></source> <volume>51</volume> <fpage>2316</fpage>&#x2013;<lpage>2321</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02669.x</pub-id> <pub-id pub-id-type="pmid">20633038</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urrestarazu</surname> <given-names>E.</given-names></name> <name><surname>Chander</surname> <given-names>R.</given-names></name> <name><surname>Dubeau</surname> <given-names>F.</given-names></name> <name><surname>Gotman</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Interictal high-frequency oscillations (100-500 Hz) in the intracerebral EEG of epileptic patients.</article-title> <source><italic>Brain</italic></source> <volume>130</volume> <fpage>2354</fpage>&#x2013;<lpage>2366</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awm149</pub-id> <pub-id pub-id-type="pmid">17626037</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burnos</surname> <given-names>S.</given-names></name> <name><surname>Hilfiker</surname> <given-names>P.</given-names></name> <name><surname>S&#x00FC;r&#x00FC;c&#x00FC;</surname> <given-names>O.</given-names></name> <name><surname>Scholkmann</surname> <given-names>F.</given-names></name> <name><surname>Krayenb&#x00FC;hl</surname> <given-names>N.</given-names></name> <name><surname>Grunwald</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Human Intracranial High Frequency Oscillations (HFOs) Detected by Automatic Time-Frequency Analysis.</article-title> <source><italic>PLoS One</italic></source> <volume>9</volume>:<fpage>e94381</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094381</pub-id> <pub-id pub-id-type="pmid">24722663</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagshaw</surname> <given-names>A. P.</given-names></name> <name><surname>Jacobs</surname> <given-names>J.</given-names></name> <name><surname>LeVan</surname> <given-names>P.</given-names></name> <name><surname>Dubeau</surname> <given-names>F.</given-names></name> <name><surname>Gotman</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Effect of sleep stage on interictal highfrequency oscillations recorded from depth macroelectrodes in patients with focal epilepsy.</article-title> <source><italic>Epilepsia</italic></source> <volume>50</volume> <fpage>617</fpage>&#x2013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01784.x</pub-id> <pub-id pub-id-type="pmid">18801037</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname> <given-names>L.</given-names></name> <name><surname>Vogrin</surname> <given-names>S.</given-names></name> <name><surname>Bailey</surname> <given-names>C.</given-names></name> <name><surname>Maixner</surname> <given-names>W.</given-names></name> <name><surname>Harvey</surname> <given-names>A. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Centre of epileptogenic tubers generate and propagate seizures in tuberous sclerosis.</article-title> <source><italic>Brain</italic></source> <volume>139</volume> <fpage>2653</fpage>&#x2013;<lpage>2667</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww192</pub-id> <pub-id pub-id-type="pmid">27497492</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>T. S.</given-names></name> <name><surname>Elliott</surname> <given-names>R. E.</given-names></name> <name><surname>Ruppe</surname> <given-names>V.</given-names></name> <name><surname>Devinsky</surname> <given-names>O.</given-names></name> <name><surname>Kuzniecky</surname> <given-names>R.</given-names></name> <name><surname>Weiner</surname> <given-names>H. L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex.</article-title> <source><italic>J. Neurosurg. Pediatr.</italic></source> <volume>10</volume> <fpage>376</fpage>&#x2013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.3171/2012.8.peds1285</pub-id> <pub-id pub-id-type="pmid">22998031</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdijadid</surname> <given-names>S.</given-names></name> <name><surname>Mathern</surname> <given-names>G. W.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.</article-title> <source><italic>CNS Neurosci. Ther.</italic></source> <volume>21</volume> <fpage>92</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12345</pub-id> <pub-id pub-id-type="pmid">25404064</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x00FC;hlebner</surname> <given-names>A.</given-names></name> <name><surname>van Scheppingen</surname> <given-names>J.</given-names></name> <name><surname>Hulshof</surname> <given-names>H. M.</given-names></name> <name><surname>Scholl</surname> <given-names>T.</given-names></name> <name><surname>Iyer</surname> <given-names>A. M.</given-names></name> <name><surname>Anink</surname> <given-names>J. J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Novel histopathological patterns in cortical tubers of epilepsy surgery patients with tuberous sclerosis complex.</article-title> <source><italic>PLoS One</italic></source> <volume>11</volume>:<fpage>e0157396</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0157396</pub-id> <pub-id pub-id-type="pmid">27295297</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname> <given-names>S.</given-names></name> <name><surname>Stewart</surname> <given-names>T.</given-names></name> <name><surname>Miller</surname> <given-names>I.</given-names></name> <name><surname>Bhatia</surname> <given-names>S.</given-names></name> <name><surname>Ragheb</surname> <given-names>J.</given-names></name> <name><surname>Duchowny</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>In vivo optical properties of cortical tubers in children with tuberous sclerosis complex (TSC): a preliminary investigation.</article-title> <source><italic>Epilepsia</italic></source> <volume>52</volume> <fpage>1699</fpage>&#x2013;<lpage>1704</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03167.x</pub-id> <pub-id pub-id-type="pmid">21762450</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krsek</surname> <given-names>P.</given-names></name> <name><surname>Jahodova</surname> <given-names>A.</given-names></name> <name><surname>Kyncl</surname> <given-names>M.</given-names></name> <name><surname>Kudr</surname> <given-names>M.</given-names></name> <name><surname>Komarek</surname> <given-names>V.</given-names></name> <name><surname>Jezdik</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Predictors of seizure-free outcome after epilepsy surgery for pediatric tuberous sclerosis complex.</article-title> <source><italic>Epilepsia</italic></source> <volume>54</volume> <fpage>1913</fpage>&#x2013;<lpage>1921</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12371</pub-id> <pub-id pub-id-type="pmid">24117179</pub-id></citation></ref>
</ref-list>
</back>
</article>